FDA Aims To Improve Product Risk Communication Under Strategic Plan

Under a plan unveiled Sept. 30, FDA aims to increase its understanding of appropriate ways to communicate with the public about product risks and to streamline its product risk communication processes

More from Archive

More from Medtech Insight